Antimicrobials in beekeeping

Wim Reybroeck1, Els Daeseleire, Hubert F De Brabander

  • 1Institute for Agricultural and Fisheries Research (ILVO), Technology and Food Science Unit, Brusselsesteenweg 370, 9090 Melle, Belgium. wim.reybroeck@ilvo.vlaanderen.be

Veterinary Microbiology
|February 21, 2012
PubMed

Insights

Treating bee diseases like American foulbrood requires antimicrobials, but regulations restrict their use due to honey residue limits. This review examines antimicrobials, their stability in honey, and hive disposition.

Area of Science:

  • Apiculture and Veterinary Science
  • Food Safety and Residue Analysis

Background:

  • Bee diseases such as American foulbrood, European foulbrood, and nosemosis pose significant threats to honeybee populations.
  • Current treatments involve anti-infectious agents, but their application is heavily regulated in major markets like the EU and USA.
  • Strict regulations stem from the lack of established Maximum Residue Limits (MRLs) for antibiotic and chemotherapeutic residues in honey, impacting trade and consumer safety.

Purpose of the Study:

  • To review existing literature on antimicrobials relevant to apiculture.
  • To assess the stability of these antimicrobials when present in honey.
  • To understand the disposition of antimicrobials within honeybee hive environments.

Main Methods:

  • Comprehensive literature search of scientific databases.
  • Analysis of studies focusing on antimicrobial efficacy against bee pathogens.
  • Review of research on the chemical stability and degradation of antimicrobials in honey.
  • Examination of studies investigating the distribution and persistence of antimicrobials in various hive components.

Main Results:

  • Identified key antimicrobials with potential for use in apiculture.
  • Highlighted significant variability in the stability of different antimicrobials within honey matrices.
  • Demonstrated that antimicrobial disposition in hives is influenced by factors such as application method, hive matrix, and environmental conditions.
  • Lack of comprehensive residue data complicates regulatory approval and safe usage.

Conclusions:

  • Effective treatment options for bee diseases exist but face regulatory hurdles due to residue concerns.
  • Further research is needed to establish stability profiles and disposition patterns for safe antimicrobial use in beekeeping.
  • Bridging the gap between therapeutic needs and regulatory requirements is crucial for sustainable apiculture.

Related Concept Videos

Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Chemical Agents for Microbial Control01:27

Chemical Agents for Microbial Control

Chemicals play important roles in controlling microbial growth by targeting microbial structures and functions as sanitizers, antiseptics, disinfectants, and sterilants.Alcohols are commonly used sanitizers, effectively disrupting lipid membranes, which compromises cell integrity. They are also used as antiseptics and disinfectants due to their rapid action and versatility.Phenols and their derivatives phenolics , known for denaturing proteins and disrupting cell membranes, are particularly...